TOPICS

Tag: Stevens-Johnson Syndrome

Toxic Epidermal Necrolysis in Pregnancy due to Ondansetron with a Favorable Outcome: A Case Report and Review of the Literature

J Clin Aesthet Dermatol. 2021;14(5):46–49. by Safoura Shakoei, MD; Maryam Daneshpazhooh, MD; Maryam Nasimi, MD; and Shahin Hamzelou, MD Drs. Shakoei and Hamzelou are with the Department of Dermatology at Imam Khomeini Hospital, Tehran University of Medical Sciences in Tehran, Iran. Drs. Daneshpazhooh and Nasimi are with the Department of Dermatology at Razi Hospital, Tehran University

CONTINUE READING »

Review of Intravenous Immunoglobulin in the Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

by Saira B. Momin, DO James Q. Del Rosso, DO, FAOCD Abstract Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare and serious cutaneous adverse reactions. There is controversy over the use of intravenous immunoglobulin (IVIG) in the treatment of SJS or TEN. The lack of randomized controlled trials to assess the benefits and

CONTINUE READING »